These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6687006)

  • 1. Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat.
    Ogren SO; Archer T; Johansson C
    Neurosci Lett; 1983 Dec; 43(2-3):327-31. PubMed ID: 6687006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.
    Archer T; Fredriksson A; Jonsson G; Lewander T; Mohammed AK; Ross SB; Söderberg U
    Psychopharmacology (Berl); 1986; 88(2):141-6. PubMed ID: 3081924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.
    Jonsson G; Hallman H; Sundström E
    Neuroscience; 1982; 7(11):2895-907. PubMed ID: 7155358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norepinephrine uptake inhibitors as biochemically and behaviorally selective antagonists of the locomotor stimulation induced by indirectly acting sympathomimetic aminetic amines in mice.
    Tyler TD; Tessel RE
    Psychopharmacology (Berl); 1980; 69(1):27-34. PubMed ID: 6771822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    Hallman H; Jonsson G
    Eur J Pharmacol; 1984 Aug; 103(3-4):269-78. PubMed ID: 6237924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment.
    Bruto V; Beauchamp C; Zacharko RM; Anisman H
    Psychopharmacology (Berl); 1984; 83(1):62-9. PubMed ID: 6429702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DSP4 alters the effect of d-amphetamine on variable-interval performance: analysis in terms of Herrnstein's equation.
    Morley MJ; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1987; 92(2):247-53. PubMed ID: 3110849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DSP4-induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion.
    Archer T; Ogren SO; Johansson G; Ross SB
    Psychopharmacology (Berl); 1982; 76(4):303-9. PubMed ID: 6812102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat.
    Archer T; Jonsson G; Ross SB
    Br J Pharmacol; 1984 May; 82(1):249-57. PubMed ID: 6733355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central noradrenaline depletion attenuates amphetamine-induced locomotor behavior.
    Mohammed AK; Danysz W; Ogren SO; Archer T
    Neurosci Lett; 1986 Feb; 64(2):139-44. PubMed ID: 3008041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of oocyte release in rats by local administration of the noradrenergic neurotoxin DSP4.
    Goldman JM; Stoker TE; Cooper RL; McElroy WK; Parrish MB
    J Reprod Fertil; 1996 Mar; 106(2):275-83. PubMed ID: 8699411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.
    Dickinson SL; Gadie B; Tulloch IF
    Psychopharmacology (Berl); 1988; 96(4):521-7. PubMed ID: 2907662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization.
    Vanderschuren LJ; Beemster P; Schoffelmeer AN
    Psychopharmacology (Berl); 2003 Sep; 169(2):176-85. PubMed ID: 12768274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [N-2-chloroethyl-N-ethyl-2-bromobenzylamine (DSP4) increases the liberation of 3H-noradrenaline produced by depolarization of the nerve ending].
    Landa ME; Rubio MC; Jaim-Etcheverry G
    Acta Physiol Pharmacol Latinoam; 1988; 38(2):167-80. PubMed ID: 2847491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4.
    Wolfman C; Abó V; Calvo D; Medina J; Dajas F; Silveira R
    Neurochem Int; 1994 Oct; 25(4):395-400. PubMed ID: 7820072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the substantia nigra in the locomotor stimulant action of amphetamine.
    Costall B; Naylor RJ
    Br J Pharmacol; 1973 Sep; 49(1):29-36. PubMed ID: 4787564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.